top of page
Sep 3, 2022
Slate Reporter Hannah Docter-Loeb and I Discuss Hemp-Derived Cannabinoids
This piece serves as a type of how to guide to all the (technically) legal cannabinoids you can buy right now.
Aug 17, 2022
I discuss delta-8-THC on podcast Cannabis Science Today
We discuss the differences between Delta-9 and Delta-8 THC and a loophole in the Farm Bill that has led to a growing, unregulated market for Delta-8.
Jun 29, 2022
ABC News Covers Our Work Documenting a Spike in Searches for Abortion Medications
This piece discusses our JAMA Internal Medicine article documenting a spike in Google searches for abortion pills especially in states with the toughest abortion restrictions.
Jun 21, 2022
TRDRP Provides Funding to Study Tobacco e-Commerce
This grant will support the development of a surveillance system for monitoring e-commerce retailers compliance with tobacco sales restrictions.
Jun 6, 2022
Use of Menthol Cigarettes, Smoking Frequency, and Nicotine Dependence Among US Youth
In this JAMA Network Open research article we demonstrate that the addition of menthol to cigarettes is associated with increased smoking frequency and nicotine dependence among US youth.
Dec 21, 2021
Public Interest in Delta-8-THC
In this research article in the International Journal of Drug Policy we document how a new hemp-derived cannabis products is taking off especially where access to recreational cannabis remains limited.
Nov 17, 2021
The Hemp Loophole
In this American Journal of Public Health editorial I discuss how Hemp Loopholes allow access to psychoactive cannabis compounds in States that prohibit recreational Cannabis use
Feb 19, 2021
E-Cigarettes and the EVALI Outbreak
Our article in BMJ Tobacco Control demonstrated that the EVALI outbreak, an outbreak of respiratory illness related vaping products, dramatically reduced online shopping for e-cigarettes and increased shopping for PMI's novel heated nicotine product IQOS rose during this outbreak.
Oct 15, 2020
CBD is Being Used as an Unproven Health Treatment
In this JAMA Network Open research article we demonstrate that despite CBD only being approved for a narrow range of applications, the public is using CBD to treat a broad range of medical conditions, many with known therapies.
Oct 15, 2020
The Need for Evidence Regarding Cannabidiol
Read NIDA deputy director Dr. Wilson Compton and Science Policy Branch Chief Dr. Emily Einstein's invited commentary of our work on the use CBD as a therapeutic.
Jul 1, 2020
The FDA Funds Research on the Impact of Menthol Cigarettes
This project will use a large national dataset to analyze the impact of menthol flavoring on cigarette consumption, dependence and quitting success.
Sep 25, 2019
Revisiting 13 Reasons Why
In this letter in JAMA Psychiatry we discuss lessons learned about how Google Search data can provide an early call to action for suicide-related media and surveillance.
May 16, 2019
In this JAMA viewpoint we discuss how few of the lessons from tobacco marketing are being applied to cannabis products presenting a case study of the manufacturer MedMen®
Jan 7, 2019
The Los Angeles Times Covers Our Work on Disparities in Smoking Prevalence Across US Cities.
This piece discusses our JAMA Internal Medicine study that finding that smoking rates are unevenly spread across neighborhoods in the United States.
Aug 1, 2017
The Atlantic Covers our Work on Netflix Show '13 Reasons Why'
This piece discusses the findings of our JAMA Internal Medicine articles documenting skyrocketing of suicide-related searches following the release of the Netflix show '13 Reasons Why'.
bottom of page